Mansoor Amiji Archives

October and November are good times to get vaccinated against COVID-19, Northeastern professors of pharmacy say. Picture here is the SARS-CoV-2 XBB 1.5 Variant. Kraken. Coronavirus. 3D Render

Is the updated COVID vaccine a good match for the current variant and the emerging strain?

Research

View

Micro dosing with the Ozempic needle injection pen is gaining in popularity, but there’s no proof it is effective, Northeastern expert says. Photo by Jaap Arriens/NurPhoto via AP

Does microdosing Ozempic work? What are experts saying about diabetes drug also used for weight loss?

Research

View

Autumn brings changing leaves-and seasonal misery for those allergic to ragweed pollen and mold. And ragweed season is just getting longer. Photo by Matthew Modoono/Northeastern University

Fall allergies are back. Why they may be worse than ever — and how to treat them

Research

View

Epipen was the only option for emergency treatment of allergic reactions, but the FDA just approved a new nasal spray that serves the same purpose. Photo by Alyssa Stone/Northeastern University

New neffy nasal spray alternative to the EpiPen could be ‘a gamechanger’ for people with allergies

Research

View

A member of the FLiRT family of COVID variants called KP.3 is the dominant variant in the U.S. Photo Matthew Modoono/Northeastern University

Will the new COVID FLiRT variant lead to a summer surge? Watch for these symptoms, experts say

Community Research

View

Moderna announces successful late trial of two-in-one mRNA shot for COVID-19 and flu. Photo Matthew Modoono/Northeastern University

Will people sign up for Moderna’s combo COVID-19-flu shot? Convenience may increase vaccinations, experts say

Community Research

View

Pharmaceutical giant AstraZeneca says its COVID-19 vaccine can cause a rare but deadly blood-clotting condition that has become the focus of a class-action lawsuit. AP Photo by: Frank Hoermann

AstraZeneca admitted in court that its vaccines can cause rare blood clotting condition. Should that give its recipients pause?

Community

View

Bouvé researchers awarded TIER 1 grants

Community Experience Global Network Research

View

Outdoor portrait photo of Mansoor Amiji, Distinguished Professor and Chair of the Department of Pharmaceutical Sciences

Bouvé’s Mansoor Amiji among three Northeastern professors recognized for extraordinary achievement in the field of medical and biological engineering

Community Research

View

12/08/23 – BOSTON, MA. – Northeastern assistant professor of pharmaceutical sciences Stephen Hatfield and his lab are researching T-Cells that hold promise of speeding up genetic treatments for cancer on Friday, Dec. 8, 2023. The goal is to develop T-cells that would be available “off the shelf” rather than having to create individualized gene T-cell therapy for each patient – which takes precious weeks. Photo by Alyssa Stone/Northeastern University

How to make mRNA therapy safe from the start

The success of mRNA vaccines against COVID-19 has unleashed a flood of interest in using the technology to create more vaccines and treatments for everything from rare diseases and infections to cancer.

Community Research

View